The global Assisted Reproductive Technology Market is in the midst of a robust expansion, driven by a combination of social and technological forces. Valued at $26.31 billion in 2023, the market is projected to reach $45 billion by 2035, growing at a CAGR of 4.58%. This growth is a direct result of the escalating rates of infertility and the continuous development of more advanced and successful ART procedures. The increasing societal acceptance of these technologies has also been a major driver, removing social stigma and encouraging more people to seek help. North America, with its market share of $10.9 billion in 2024, is a dominant force in this sector, leading in both technological adoption and market value.
The market's growth is heavily influenced by the demand for key procedures. IVF, a foundational ART procedure, is projected to grow from $10.0 billion in 2024 to $16.5 billion by 2035. ICSI is also a key growth area, with a projected value of $11.0 billion by 2035, demonstrating its increasing importance in addressing male factor infertility.